For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...

Scientists are laying the groundwork for treating one of the most common genetic conditions in humans. Research out today ...

CRISPR Cas9 genome editing has transformed the way scientists approach gene therapy, acting like precise DNA scissors that can target and repair hereditary diseases at the genetic level. This ...

The last time The Lancet Microbe featured an Editorial on CRISPR was in November 2020, to mark that year’s Nobel Prize in Chemistry, jointly awarded to Emmanuelle Charpentier and Jennifer A Doudna for ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...

The ACC has published a scientific statement regarding the use of gene editing therapy for cardiovascular disease.

The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...

The US Food and Drug Administration released a draft guidance document on Tuesday with recommendations for using ...